Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kompella Uday, Director. Director active across 1 company, notably Ocugen, Inc.. Aggregated, 8 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €2.1m. Activity tracked since 30 April 2021. The latest transaction was filed on 1 November 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Kompella Uday is Administrateur at Ocugen, Inc. (XNAS). The 16 filings recorded are all sales, with 0 EUR in purchases and 4,259,046 EUR in sales over the period covered by the sampled recent filings, from 2021-05-03 to 2021-11-03.